文献速递关节外科

全膝关节置换术后抗凝药类型影响术后僵硬需麻醉下手法松解的发生率

Type of Anticoagulant Used After Total Knee Arthroplasty Affects the Rate of Knee Manipulation for Postoperative Stiffness.
PubMed 文献 · J Bone Joint Surg Am · 2018-01-01

基于PearlDiver数据库分析2007至2015年32,320例初次单侧全膝关节置换患者,比较不同抗凝药与术后6个月内麻醉下手法松解(MUA)风险的关系。以低分子肝素为参照,华法林(HR 1.17)、直接Xa因子抑制剂(HR 1.42)和磺达肝癸钠(HR 1.33)的MUA风险显著增加,阿司匹林无显著增加(HR 1.17,95%CI 0.72-1.80,p=0.493)。作者建议对口服抗凝药患者告知僵硬风险,并在选择血栓预防方案时考虑这些数据。

要点

  • 术后最常用抗凝药为华法林(38.0%),其次为低分子肝素(33.8%)。
  • 32,320例中1,178例(3.64%)在术后6个月内接受麻醉下手法松解。
  • 以低分子肝素为参照,华法林、直接Xa因子抑制剂和磺达肝癸钠的MUA风险显著增加。

核心结论

  • 与低分子肝素相比,接受华法林、直接Xa因子抑制剂或磺达肝癸钠的患者全膝关节置换术后麻醉下手法松解率增加。
  • 作者推荐对全膝关节置换术后接受口服抗凝药的患者告知相关僵硬风险。
  • 作者建议外科医生在选择全膝关节置换术后血栓预防方案时考虑这些数据。

研究设计与样本

  • 基于PearlDiver患者数据库的人群水平分析,纳入2007至2015年32,320例初次单侧全膝关节置换患者。
  • 纳入标准为出院后2天内填写抗凝药处方;排除全膝关节置换前3个月内使用处方抗凝药(阿司匹林除外)者。
  • 主要结局为初次全膝关节置换术后6个月内行麻醉下手法松解。

主要发现

  • 术后最常用抗凝药为华法林(38.0%),其次为低分子肝素(33.8%)。
  • 32,320例中1,178例(3.64%)在术后6个月内接受麻醉下手法松解。
  • 以低分子肝素为参照并校正年龄、性别、合并症和住院时间后,华法林组MUA风险显著增加(HR 1.17,95%CI 1.01-1.36,p=0.032)。
  • 直接Xa因子抑制剂组MUA风险显著增加(HR 1.42,95%CI 1.20-1.66,p<0.001)。
  • 磺达肝癸钠组MUA风险显著增加(HR 1.33,95%CI 1.01-1.72,p=0.038)。

关键数值与推荐

  • 证据等级:治疗性III级。

临床怎么用

  • 作者推荐对全膝关节置换术后接受口服抗凝药的患者告知相关僵硬风险。
  • 作者建议外科医生在选择全膝关节置换术后血栓预防方案时考虑这些数据。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of this study was to perform a population-level analysis on the effect of different types of anticoagulation on postoperative stiffness after total knee replacement, requiring manipulation under anesthesia. We hypothesized that patients receiving warfarin would have a higher rate of manipulation under anesthesia compared with patients receiving low-molecular-weight heparin. We also hypothesized that aspirin, direct factor Xa inhibitors, and fondaparinux would have no effect on the rate of manipulation under anesthesia. METHODS: Using the PearlDiver patient database, we analyzed 32,320 patients who underwent a primary unilateral total knee replacement from 2007 to 2015. Patients were included if they filled a prescription for anticoagulation medication within 2 days of their discharge and were excluded if they were taking a prescription anticoagulation medication (except for aspirin) in the 3 months before total knee replacement. The primary outcome was manipulation under anesthesia performed within 6 months after a primary total knee replacement. RESULTS: The most commonly prescribed postoperative anticoagulation was warfarin (38.0%), followed by low-molecular-weight heparin (33.8%). There were 1,178 patients (3.64%) who underwent manipulation under anesthesia within 6 months of total knee replacement. In multivariable analysis using low-molecular-weight heparin as a comparison group and accounting for age, sex, comorbidities, and length of stay, there was a significant increase in the risk of manipulation under anesthesia for patients who received warfarin (hazard ratio [HR], 1.17 [95% confidence interval (CI), 1.01 to 1.36]; p = 0.032), direct factor Xa inhibitors (HR, 1.42 [95% CI, 1.20 to 1.66]; p < 0.001), or fondaparinux (HR, 1.33 [95% CI, 1.01 to 1.72]; p = 0.038). Although patients who received aspirin had the same risk estimate as patients who received warfarin, there was not a significantly increased risk of manipulation under anesthesia in patients who received aspirin compared with low-molecular-weight heparin (HR, 1.17 [95% CI, 0.72 to 1.80]; p = 0.493). CONCLUSIONS: We found an increased rate of manipulation under anesthesia after total knee replacement in patients who received oral anticoagulants including warfarin, direct factor Xa inhibitors, and fondaparinux, in comparison with patients who received aspirin or low-molecular-weight heparin. We recommend that patients receiving oral anticoagulants after total knee replacement should be counseled about associated stiffness. Furthermore, surgeons should take these data into account when selecting thromboprophylaxis for patients after total knee replacement. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Kahlenberg CA, Richardson SS, Schairer WW, et al. Type of Anticoagulant Used After Total Knee Arthroplasty Affects the Rate of Knee Manipulation for Postoperative Stiffness. J Bone Joint Surg Am. 2018. PMID: 30106817. doi:10.2106/JBJS.17.01110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。